We are monitoring the impact of COVID-19 on APAC Migraine Drug Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 3953
Share on
Share on

Asia-Pacific Migraine Drug Market Research Report - Segmented By Treatment, Therapeutic Class & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC)- Industry Analysis, Size, Share, Trends & Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 3953
Pages: 148

APAC Migraine Drug Market Size (2020 to 2025)

As per the research report, the Asia-Pacific Migraine Drug Market size has been calculated at USD 0.72 billion in 2020. It is estimated to be growing at a CAGR of 5.51% and worth USD 0.95 billion by 2025.

The chronic daily headache (CDH) prevalence in Asia might be lower than the global average. However, Data collected based on the population for Chronic Migraine (CM) remains low, and there are many classification variations.

Asia-Pacific Migraine Drug Market is increasing at a slow rate due to growth in the generalization of drugs. The market is witnessing a huge number of unmet needs because of no permanent cure for the disease. This attracted investors to make huge investments in R&D. Companies that manufacture and sell drugs that show efficacy profile and high safety are estimated to be competitive to their peers.

The growing requirement for new treatment choices has driven the improvement of new devices, for example, antimigraine devices and headbands in the market. For example, Cefaly Transcutaneous Electrical Nerve Stimulation devices is an FDA affirmed devices for headache treatment. This device animates the trigeminal nerve by emanating electric streams and gives a reduction from headache. Expanding spending in new research exercises and novel item advancements are relied upon to quicken this market's development and improvement throughout the following four years.

This research report on the Asia-Pacific Migraine Drugs Market has been segmented and sub-segmented into the following categories:

By Treatment: 

  • Preventive
  • Absorptive

By Therapeutic Class: 

  • Triptants
  • Ergots
  • Others

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Some of the companies dominating the APAC Migraine Drug Market profiled in the report are Allergan, GlaxoSmithKline, Pfizer, Endo, Impax Laboratories. The other prominent vendors in the market include AbbottAeriel BioPharma, Alder Biopharmaceuticals, Amgen, Astellas, Bayer, CoLucid, Eli Lilly, IntelGenx, Ethypharm, Johnson & Johnson, Kowa Pharmaceuticals America, Klaria, Luitpold Pharmaceuticals, AstraZeneca, Meda, Dr. Reddy's Laboratories,  OptiNose, Pfizer, Pozen, Eisai, Raptor, RedHill, SUDA, Teva, Aegis Therapeutics, Merck, TG Therapeutics, NValeant, Winston Pharmaceuticals, Allergan,  and Zogenix.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods   

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Preventive              

                                5.1.3 Abortive   

                                5.1.4  Y-o-Y Growth Analysis, By Treatment         

                                5.1.5  Market Attractiveness Analysis, By Treatment       

                                5.1.6  Market Share Analysis, By Treatment        

                5.2 Therapeutic                

                                5.2.1 Introduction           

                                5.2.2 Triptents  

                                5.2.3 Ergots        

                                5.2.4 Others      

                                5.2.5 Y-o-Y Growth Analysis, By Therapeutic       

                                5.2.6 Market Attractiveness Analysis, By Therapeutic     

                                5.2.7 Market Share Analysis, By Therapeutic       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment

                                                6.1.3.3 By Therapeutic

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment

                                                6.1.4.3 By Therapeutic

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment

                                                6.1.5.3 By Therapeutic

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Allergan                       

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Endo International                  

                8.3  GlaxoSmithKline                      

                8.4 Impax                           

                8.5 Pfizer                            

                8.6 Aegis Therapeutics                  

                8.7 Alder Biopharmaceuticals                     

                8.8 Astellas                        

                8.9 AstraZeneca                               

                8.10 Aeriel BioPharma                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in daetail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environmentGlobal Medical Aesthetics Devices Market, Medical Aesthetics Devices Market research report, Medical Aesthetics Devices industry analysis
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Migraine Drug Market, By Treatment, From 2020 to 2025 (USD Billion)
  2. Asia-Pacific Preventive Market, By Region, From 2020 to 2025 (USD Billion)
  3. Asia-Pacific abortive Market, By Region, From 2020 to 2025 (USD Billion)
  4. Asia-Pacific Migraine Drug Market, By Therapeutic, From 2020 to 2025 (USD Billion)
  5. Asia-Pacific Triptents Market, By Region, From 2020 to 2025 (USD Billion)
  6. Asia-Pacific Ergots Market, By Region, From 2020 to 2025 (USD Billion)
  7. Asia-Pacific Others Market, By Region, From 2020 to 2025 (USD Billion)
  8. Japan Migraine Drug Market, By Treatment, From 2020 to 2025 (USD Billion)
  9. Japan Migraine Drug Market, By Therapeutic, From 2020 to 2025 (USD Billion)
  10. China Migraine Drug Market, By Treatment, From 2020 to 2025 (USD Billion)
  11. China Migraine Drug Market, By Therapeutic, From 2020 to 2025 (USD Billion)
  12. India Migraine Drug Market, By Treatment, From 2020 to 2025 (USD Billion)
  13. India Migraine Drug Market, By Therapeutic, From 2020 to 2025 (USD Billion)
  14. Australia Migraine Drug Market, By Treatment, From 2020 to 2025 (USD Billion)
  15. Australia Migraine Drug Market, By Therapeutic, From 2020 to 2025 (USD Billion)
  16. South Korea Migraine Drug Market, By Treatment, From 2020 to 2025 (USD Billion)
  17. South Korea Migraine Drug Market, By Therapeutic, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample